Susquehanna International Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Susquehanna International Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-46,519	Closed	-$868K	–	14536
2022 Q1	$868K	Sell	46,519 -24,725	-35%	-$445K	﹤0.01%	7497
2021 Q4	$1.52M	Buy	71,244 +43,178	+154%	+$851K	﹤0.01%	6170
2021 Q3	$519K	Buy	+28,066	New	+$565K	﹤0.01%	9300

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's OCDX Position: Q2 2022 in Review

Susquehanna International Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 46,519 shares — an estimated $868K sold.

Susquehanna International Group first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $1.52M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Susquehanna International Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Susquehanna International Group sold 46,519 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $868K.
Susquehanna International Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
Susquehanna International Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.52M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.